Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2024-11-04 00:00:00 ET · period of report 2024-11-01 · accession 0000917520-24-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-04 | 2024-11-01 | IART | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | +9,814 | 28.2K | +53% | $0 |
| D | 2024-11-04 | 2024-11-01 | IART | De Witte Jan | Pres, CEO, Dir | F - Tax | $19.28 | -4,262 | 23.9K | -15% | -$82.2K |
| D | 2024-11-04 | 2024-11-01 | IART | De Witte Jan | Pres, CEO, Dir | M - OptEx | $0.00 | -9,814 | 120.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | M | A | 9,814 | $0.00 | 28,164 | D | — | — | (F1) On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The second installment vested on 11/1/2024. |
| 2 | Common | Common Stock | 2024-11-01 | F | D | 4,262 | $19.28 | 23,902 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-11-01 | M | D | 9,814 | $0.00 | 120,466 | D | $0.00 · — to — | 9,814 Common Stock | (F1) On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The second installment vested on 11/1/2024. |